Our study may have a significant impact on determining the therapeutic efficacy of novel STAT3/5 small molecule inhibitors such as SH-4-54 aimed at treating breast cancer and other aggressive cancers in which the ying-yang effects of STAT proteins play a central role, such as leukemias. The gene discussed is STAT3; the disease is breast cancer.